Is Theriva Biologics (TOVX) a buy or sell right now?
Based on aggregated sentiment from Reddit and X sources, Theriva Biologics (TOVX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 37% bullish across 2 active sources. Those sources contribute 47 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
What does Reddit say about TOVX stock?
Reddit discussion around Theriva Biologics (TOVX) is fairly quiet with 3 mentions across 2 tracked subreddits. The tone is 33% bullish with rising 3-day activity momentum, suggesting building attention.
What is the sentiment on TOVX stock?
Theriva Biologics (TOVX) sentiment is bearish across all 2 tracked sources. X reads 41% bullish and reddit coverage is the most negative at 33% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Why does TOVX carry a sell signal right now?
Social sentiment data shows consistently bearish discussion around Theriva Biologics (TOVX). All 2 tracked sources lean negative, with reddit being the most bearish at 33% bullish. 3-day activity momentum is falling on X, while reddit activity is rising. The sell signal carries 93/100 conviction.
What is driving Theriva Biologics (TOVX) sentiment right now?
X is the dominant discussion channel with 44 mentions (94% of total volume). Reddit contributes 3 mentions. Sentiment is bearish across all sources, while reddit is the only source with rising 3-day activity.
What does the Adanos sell signal mean for Theriva Biologics (TOVX)?
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. TOVX's sell signal at 93/100 conviction reflects consistently bearish sentiment across multiple platforms. It is a research shortcut, not financial advice.
How fresh is this TOVX sentiment data?
The TOVX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.